Literature DB >> 7669599

Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives.

J W Mant1, M P Vessey.   

Abstract

Numerous case-control studies have suggested a link between the oral contraceptive pill and liver cancer. The secular trends in liver cancer mortality rates for England and Wales from 1975 to 1992 were examined to determine whether an effect of the pill was apparent. Liver cancer mortality has remained constant in women in the age groups that have had major exposure to the pill.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7669599      PMCID： PMC2033882          DOI： 10.1038/bjc.1995.415

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  15 in total

1.  The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.

Authors:  L Villard-Mackintosh; M P Vessey; L Jones
Journal:  Br J Obstet Gynaecol       Date:  1989-07

2.  Cancer of the liver and the use of oral contraceptives.

Authors:  D Forman; T J Vincent; R Doll
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

3.  Oral contraceptives and hepatocellular carcinoma.

Authors:  J Neuberger; D Forman; R Doll; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

4.  Contraceptive steroids as a risk factor for hepatocellular carcinoma: a case/control study in South African black women.

Authors:  M C Kew; E Song; A Mohammed; J Hodkinson
Journal:  Hepatology       Date:  1990-02       Impact factor: 17.425

5.  Oral contraceptive use and liver cancer.

Authors:  J R Palmer; L Rosenberg; D W Kaufman; M E Warshauer; P Stolley; S Shapiro
Journal:  Am J Epidemiol       Date:  1989-11       Impact factor: 4.897

6.  Oral contraceptives and primary liver cancer among young women.

Authors:  A W Hsing; R N Hoover; J K McLaughlin; H T Co-Chien; S Wacholder; W J Blot; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

7.  Oral contraceptives and primary liver cancer.

Authors:  C La Vecchia; E Negri; F Parazzini
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

8.  Hepatocellular carcinoma and oral contraceptives.

Authors:  B E Henderson; S Preston-Martin; H A Edmondson; R L Peters; M C Pike
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

9.  Female hormone utilisation and risk of hepatocellular carcinoma.

Authors:  A Tavani; E Negri; F Parazzini; S Franceschi; C La Vecchia
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

10.  Trends in mortality from carcinoma of the liver and the use of oral contraceptives.

Authors:  D Forman; R Doll; R Peto
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640
View more
  3 in total

1.  Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.

Authors:  Cong Peng; Rou-Li Zhou; Gen-Ze Shao; Jing-An Rui; Shao-Bin Wang; Ming Lin; Sha Zhang; Zi-Feng Gao
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

Review 2.  Oral contraceptives and cancer. A review of the evidence.

Authors:  C La Vecchia; A Tavani; S Franceschi; F Parazzini
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

3.  Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.

Authors:  Dongyun Yang; Diana L Hanna; Josh Usher; Jordan LoCoco; Pritesh Chaudhari; Heinz-Josef Lenz; V Wendy Setiawan; Anthony El-Khoueiry
Journal:  Cancer       Date:  2014-07-31       Impact factor: 6.921
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.